Current
Neuro-Oncology


Volume 20 Number 12
31 December 2018


Home > Publications > Current Neuro-Oncology > Volume 20, Year 2018 > Number 12, 31 Decemcer






Toms SA, Kim CY, Nicholas G, Ram Z.
Increased compliance with tumor treating fields therapy is prognostic for improved survival in the treatment of glioblastoma: a subgroup analysis of the EF-14 phase III trial.
J Neurooncol. 2018 Dec 1, 2019;141(2):467-473. doi: 10.1007/s11060-018-03057-z. PMID: 30506499. Interventional study. ˍ




Lombardi G, De Salvo GL, Brandes AA, Eoli M, Rudà R, Faedi M, Lolli I, Pace A, Daniele B, Pasqualetti F, Rizzato S, Bellu L, Pambuku A, Farina M, Magni G, Indraccolo S, Gardiman MP, Soffietti R, Zagonel V.
Regorafenib compared with lomustine in patients with relapsed glioblastoma (REGOMA): a multicentre, open-label, randomised, controlled, phase 2 trial.
Lancet Oncol. 2018 Dec 3, 2019;20(1):110-119. doi: 10.1016/S1470-2045(18)30675-2. PMID: 30522967. Interventional study. ˍ




Navarria P, Minniti G, Clerici E, Tomatis S, Pinzi V, Ciammella P, Galaverni M, Amelio D, Scartoni D, Scoccianti S, Krengli M, Masini L, Draghini L, Maranzano E, Borzillo V, Muto P, Ferrarese F, Fariselli L, Livi L, Pasqualetti F, Fiorentino A, Alongi F, di Monale MB, Magrini S, Scorsetti M.
Re-irradiation for recurrent glioma: outcome evaluation, toxicity and prognostic factors assessment. A multicenter study of the Radiation Oncology Italian Association (AIRO).
J Neurooncol. 2018 Dec 4, 2019;142(1):59-67. doi: 10.1007/s11060-018-03059-x. PMID: 30515706. Observational study. ˍ




Diaz-Aguilar D, ReFaey K, Clifton W, Durcanova B, Chen SG, Deen HG, Bydon M, Trifiletti DM, Pichelmann MA, Quiñones-Hinojosa A.
Prognostic factors and survival in low grade gliomas of the spinal cord: A population-based analysis from 2006 to 2012.
J Clin Neurosci. 2018 Dec 5, 2019;61:14-21. doi: 10.1016/j.jocn.2018.11.025. PMID: 30528541. Observational study. ˍ




Dawes W, Marcus HJ, Tisdall M, Aquilina K.
Robot-assisted stereotactic brainstem biopsy in children: prospective cohort study.
J Robot Surg. 2018 Dec 6, 2019;13(4):575-579. doi: 10.1007/s11701-018-0899-x. PMID: 30523502. Interventional study. ˍ




Fabbro-Peray P, Zouaoui S, Darlix A, Fabbro M, Pallud J, Rigau V, Mathieu-Daude H, Bessaoud F, Bauchet F, Riondel A, Sorbets E, Charissoux M, Amelot A, Mandonnet E, Figarella-Branger D, Duffau H, Tretarre B, Taillandier L, Bauchet L.
Association of patterns of care, prognostic factors, and use of radiotherapy-temozolomide therapy with survival in patients with newly diagnosed glioblastoma: a French national population-based study.
J Neurooncol. 2018 Dec 6, 2019;142(1):91-101. doi: 10.1007/s11060-018-03065-z. PMID: 30523606. Observational study. ˍ




Alkhaibary A, Alassiri AH, AlSufiani F, Alharbi MA.
Ki-67 labeling index in glioblastoma; does it really matter?
Hematol Oncol Stem Cell Ther. 2018 Dec 8, 2019;12(2):82-88. doi: 10.1016/j.hemonc.2018.11.001. PMID: 30552865. Observational study. ˍ




Dührsen L, Sauvigny T, Ricklefs FL, Mende KC, Schaper M, Matschke J, Goebell E, Westphal M, Martens T.
Seizures as presenting symptom in patients with glioblastoma.
Epilepsia. 2018 Dec 9, 2019;60(1):149-154. doi: 10.1111/epi.14615. PMID: 30536819. Observational study. ˍ




Karipidis K, Elwood M, Benke G, Sanagou M, Tjong L, Croft RJ.
Mobile phone use and incidence of brain tumour histological types, grading or anatomical location: a population-based ecological study.
BMJ Open. 2018 Dec 9, 2018;8(12):e024489→. doi: 10.1136/bmjopen-2018-024489→. PMID: 30530588. Observational study. ˍ
Erratum for: Mobile phone use and incidence of brain tumour histological types, grading or anatomical location: a population-based ecological study. BMJ Open. 2019 Jan 29, 2019;9(1):e024489corr1. doi: 10.1136/bmjopen-2018-024489corr1. PMID: 30782766. Correction. ˍ




D'Angelo F, Ceccarelli M, Tala, Garofano L, Zhang J, Frattini V, Caruso FP, Lewis G, Alfaro KD, Bauchet L, Berzero G, Cachia D, Cangiano M, Capelle L, de Groot J, DiMeco F, Ducray F, Farah W, Finocchiaro G, Goutagny S, Kamiya-Matsuoka C, Lavarino C, Loiseau H, Lorgis V, Marras CE, McCutcheon I, Nam DH, Ronchi S, Saletti V, Seizeur R, Slopis J, Suñol M, Vandenbos F, Varlet P, Vidaud D, Watts C, Tabar V, Reuss DE, Kim SK, Meyronet D, Mokhtari K, Salvador H, Bhat KP, Eoli M, Sanson M, Lasorella A, Iavarone A.
The molecular landscape of glioma in patients with Neurofibromatosis 1.
Nat Med. 2018 Dec 10, 2019;25(1):176-187. doi: 10.1038/s41591-018-0263-8. PMID: 30531922. Laboratory investigation. ˍ




Karlsson I, Veevnik D, Fedulov A, Yurkshtovich N, Yurkshtovich T, Pejler G, Lokot I.
Local delivery of temozolomide via a biologically inert carrier (Temodex) prolongs survival of glioma patients irrespectively of the MGMT methylation status.
Neoplasma. 2018 Dec 12, 2019;66(2):288-293. doi: 10.4149/neo_2018_180613N393. PMID: 30569719. Interventional study. ˍ




Cobbs C, McClay E, Duic JP, Nabors LB, Morgan Murray D, Kesari S.
An early feasibility study of the Nativis Voyager® device in patients with recurrent glioblastoma: first cohort in US.
CNS Oncol. 2018 Dec 14, 2019;8(1):CNS30. doi: 10.2217/cns-2018-0013. PMID: 30547676. Interventional study. ˍ




Kwan K, Schneider JR, Patel NV, Boockvar JA.
Tracing the Origin of Glioblastoma: Subventricular Zone Neural Stem Cells.
Neurosurgery.
2018 Dec 14, 2019;84(1):E15-E16. doi: 10.1093/neuros/nyy512. PMID: 30551194. Comment. ˍ
Refers to: Lee JH, et al., Human glioblastoma arises from subventricular zone cells with low-level driver mutations.
Nature. 2018 Aug 1, 2018 Aug;560(7717):243-247. doi: 10.1038/s41586-018-0389-3. PMID: 30069053. Laboratory investigation. ˍ




Iwadate Y, Matsutani T, Hara A, Hirono S, Ikegami S, Kobayashi M, Ito D, Kawauchi D, Horiguchi K, Tamiya A, Higuchi Y.
Eighty percent survival rate at 15 years for 1p/19q co-deleted oligodendroglioma treated with upfront chemotherapy irrespective of tumor grade.
J Neurooncol. 2018 Dec 18, 2019;141(1):205-211. doi: 10.1007/s11060-018-03027-5. PMID: 30565028. Observational study. ˍ




Jussila MP, Remes T, Anttonen J, Harila-Saari A, Niinimäki J, Pokka T, Koskenkorva P, Sutela A, Toiviainen-Salo S, Arikoski P, Riikonen P, Arola M, Lähteenmäki P, Sirkiä K, Rantala H, Suo-Palosaari M, Ojaniemi M.
Late vertebral side effects in long-term survivors of irradiated childhood brain tumor.
PLoS One. 2018 Dec 18, 2018;13(12):e0209193. doi: 10.1371/journal.pone.0209193. PMID: 30562369. Observational study. ˍ




Ge X, Xue X, Liu H, Wang Y, Xiao Z, Tian L, Chang X, Lin Q, Yu J.
Treatment of high-grade gliomas using escalating doses of hypofractionated simultaneous integrated boost-intensity-modulated radiation therapy in combination with temozolomide: A modified Phase I clinical trial.
J Cancer Res Ther. 2018 Dec 19, 2018;14(7):1482-1491. doi: 10.4103/jcrt.JCRT_51_18. PMID: 30589027. Interventional study. ˍ




Hilf N, Kuttruff-Coqui S, Frenzel K, Bukur V, Stevanović S, Gouttefangeas C, Platten M, Tabatabai G, Dutoit V, van der Burg SH, Thor Straten P, Martínez-Ricarte F, Ponsati B, Okada H, Lassen U, Admon A, Ottensmeier CH, Ulges A, Kreiter S, von Deimling A, Skardelly M, Migliorini D, Kroep JR, Idorn M, Rodon J, Piró J, Poulsen HS, Shraibman B, McCann K, Mendrzyk R, Löwer M, Stieglbauer M, Britten CM, Capper D, Welters MJP, Sahuquillo J, Kiesel K, Derhovanessian E, Rusch E, Bunse L, Song C, Heesch S, Wagner C, Kemmer-Brück A, Ludwig J, Castle JC, Schoor O, Tadmor AD, Green E, Fritsche J, Meyer M, Pawlowski N, Dorner S, Hoffgaard F, Rössler B, Maurer D, Weinschenk T, Reinhardt C, Huber C, Rammensee HG, Singh-Jasuja H, Sahin U, Dietrich PY, Wick W.
Actively personalized vaccination trial for newly diagnosed glioblastoma.
Nature. 2018 Dec 19, 2019;565(7738):240-245. doi: 10.1038/s41586-018-0810-y. PMID: 30568303. Interventional study. ˍ




Keskin DB, Anandappa AJ, Sun J, Tirosh I, Mathewson ND, Li S, Oliveira G, Giobbie-Hurder A, Felt K, Gjini E, Shukla SA, Hu Z, Li L, Le PM, Allesøe RL, Richman AR, Kowalczyk MS, Abdelrahman S, Geduldig JE, Charbonneau S, Pelton K, Iorgulescu JB, Elagina L, Zhang W, Olive O, McCluskey C, Olsen LR, Stevens J, Lane WJ, Salazar AM, Daley H, Wen PY, Chiocca EA, Harden M, Lennon NJ, Gabriel S, Getz G, Lander ES, Regev A, Ritz J, Neuberg D, Rodig SJ, Ligon KL, Suvà ML, Wucherpfennig KW, Hacohen N, Fritsch EF, Livak KJ, Ott PA, Wu CJ, Reardon DA.
Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial.
Nature. 2018 Dec 19, 2019;565(7738):234-239
. doi: 10.1038/s41586-018-0792-9. PMID: 30568305. Interventional study. ˍ




Zhukova N, Rajagopal R, Lam A, Coleman L, Shipman P, Walwyn T, Williams M, Sullivan M, Campbell M, Bhatia K, Gottardo NG, Hansford JR.
Use of bevacizumab as a single agent or in adjunct with traditional chemotherapy regimens in children with unresectable or progressive low-grade glioma.
Cancer Med. 2018 Dec 19, 2019;8(1):40-50. doi: 10.1002/cam4.1799. PMID: 30569607. Observational study. ˍ




Zschaeck S, Wust P, Graf R, Misch M, Onken J, Ghadjar P, Badakhshi H, Florange J, Budach V, Kaul D.
Locally dose-escalated radiotherapy may improve intracranial local control and overall survival among patients with glioblastoma.
Radiat Oncol. 2018 Dec 19, 2018;13(1):251. doi: 10.1186/s13014-018-1194-8. PMID: 30567592. Observational study. ˍ




Ene CI, Macomber MW, Barber JK, Ferreira MJ, Ellenbogen RG, Holland EC, Rockhill JK, Silbergeld DL, Halasz LM.
Patterns of Failure After Stereotactic Radiosurgery for Recurrent High-Grade Glioma: A Single Institution Experience of 10 Years.
Neurosurgery. 2018 Dec 20, 2019;85(2):E322-E331. doi: 10.1093/neuros/nyy520. PMID: 30576476. Observational study. ˍ




Matsuo S, Amano T, Kawauchi S, Nakamizo A.
Multiple brain metastases from pancreatic adenocarcinoma presenting with simultaneous intratumoral hemorrhages: A case report.
World Neurosurg. 2018 Dec 20, 2019;123:221-225. doi: 10.1016/j.wneu.2018.12.036. PMID: 30579022. Case report. ˍ




Petzold J, Severus E, Meyer S, Bauer M, Daubner D, Krex D, Juratli TA.
Glioblastoma multiforme presenting as postpartum depression: a case report.
J Med Case Rep. 2018 Dec 20, 2018;12(1):374. doi: 10.1186/s13256-018-1909-3. PMID: 30567605. Case report. ˍ




Al-Mayhani T, Heywood R, Vemireddy V, Lathia JD, Piccirillo SGM, Watts C.
A Non-Hierarchical Organisation of Tumorigenic NG2 Cells in Glioblastoma promoted by EGFR.
Neuro Oncol. 2018 Dec 22,
2019;21(6):719-729. doi: 10.1093/neuonc/noy204. PMID: 30590711. Laboratory investigation. ˍ




Hesari A, Rezaei M, Rezaei M, Dashtiahangar M, Fathi M, Rad JG, Momeni F, Avan A, Ghasemi F.
Effect of curcumin on glioblastoma cells.
J Cell Physiol. 2018 Dec 26, 2019;234(7):10281-10288. doi: 10.1002/jcp.27933. PMID: 30585634. Laboratory investigation. ˍ




Hou BL, Wen S, Katsevman GA, Liu H, Urhie O, Turner RC, Carpenter J, Bhatia S.
Magnetic Resonance Imaging Parameters and Their Impact on Survival of Patients with Glioblastoma: Tumor Perfusion Predicts Survival.
World Neurosurg. 2018 Dec 27, 2019;124:e285-e295.ˍ. doi: 10.1016/j.wneu.2018.12.085. PMID: 30593971. Observational study. ˍ




Finch EA, Elton SW, Huang BY, Trembath DG, Blatt J.
Long-term Efficacy of Single-agent Vemurafenib for Pleomorphic Xanthoastrocytoma.
J Pediatr Hematol Oncol. 2018 Dec 27, 2020;42(2):152-155. doi: 10.1097/MPH.0000000000001395. PMID: 30601402. Case report. ˍ




Schou Nørøxe D, Regner Michaelsen S, Broholm H, Møller S, Skovgaard Poulsen H, Lassen U.
Extracranial metastases in glioblastoma-Two case stories.
Clin Case Rep. 2018 Dec 27, 2018;7(2):289-294
. doi: 10.1002/ccr3.1980. PMID: 30847191. Case report. ˍ




Long S, Li M, Ou S, Li G.
The effect of marital status on glioma patient survival: analysis of 617 cases: A SEER-based study.
Medicine (Baltimore). 2018 Dec 28, 2018;97(52):e13900. doi: 10.1097/MD.0000000000013900. PMID: 30593203. Observational study. ˍ




Viderman D, Nurpeissov A, Bilotta F.
Intravenous lidocaine in the management of severe brain tumor-associated headache.
J Clin Anesth. 2018 Dec 28, 2019;55:67-68. doi: 10.1016/j.jclinane.2018.12.053. PMID: 30597454. Case report. ˍ




Aminianfar A, Shayanfar M, Mohammad-Shirazi M, Sharifi G, Esmaillzadeh A.
Egg Consumption in Relation to Glioma: A Case-Control Study.
Nutr Cancer. 2018 Dec 29, 2019;71(1):41-49. doi: 10.1080/01635581.2018.1540712. PMID: 30596269. Observational study. ˍ




Garcia CR, Villamar MF, Villano JL.
Intraventricular Glioblastoma.
Neurohospitalist. 2018 Dec 30, 2019;9(4):239-240. doi: 10.1177/1941874418817950. PMID: 31534616. Case report. ˍ




Lehrer S, Rheinstein PH, Rosenzweig KE.
Allergy may confer better survival on patients with gliomas.
Clin Neurol Neurosurg. 2018 Dec 31, 2019;177:63-67. doi: 10.1016/j.clineuro.2018.12.021. PMID: 30611004. Observational study. ˍ




Shapira-Furman T, Serra R, Gorelick N, Doglioli M, Tagliaferri V, Cecia A, Peters M, Kumar A, Rottenberg Y, Langer R, Brem H, Tyler B, Domb AJ.
Biodegradable wafers releasing Temozolomide and Carmustine for the treatment of brain cancer.
J Control Release. 2018 Dec 31, 2019;295:93-101. doi: 10.1016/j.jconrel.2018.12.048. PMID: 30605703. Laboratory investigation. ˍ